The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS

CompletedOBSERVATIONAL
Enrollment

2,973

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions
Respiratory Distress SyndromeBronchopulmonary Dysplasia
Trial Locations (29)

TN24 0LZ

William Harvey Hospital, Ashford

B15 2TG

Birmingham Women's Hospital, Birmingham

B9 5SS

Birmigham Heartlands Hospital, Birmingham

BL4 0JR

Royal Bolton Hospital, Bolton

Unknown

Bradford Royal Infirmary, Bradford

University Hospital of North Tees, Middlesbrough

BB10

Burnley General Hospital, Burnley

CB2 0SW

The Rosie Hospital, Cambridge

KT16 0PZ

St Peter's Hospital, Chertsey

CV2 2DX

University Hospital Coventry, Coventry

HU3 2JZ

Hull Royal Infirmary, Hull

LS1 3EX

Leeds General Infirmary, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

L8 7SS

Liverpool Women's Hospital, Liverpool

E9 6SR

Homerton Hospital, London

NW1 2BU'

University College Hospital, London

SE1 7EH

Guy's and St Thomas' Hospital, London

SW10 9NH

Chelsea and Westminster Hospital, London

M13 9WL

St Mary's Hospital, Manchester

M13

Wythenshawe Hospital, Manchester

TS4 3BW

The James Cook Hospital, Middlesbrough

Ne1 4LP

Royal Victoria Infirmary, Newcastle

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

NG7 2UH

Queens Medical Centre, Nottingham

OL1 2JH

Royal Oldham Hospital, Oldham

OX3 9DU

John Radcliffe Hospital, Oxford

PO6 3LY

Queen Alexandra Hospital, Portsmouth

S10 2SF

Jessop Wing, Sheffield

SO16 6YD

Princess Anne Hospital, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Imperial College London

OTHER

lead

Chiesi UK

INDUSTRY

NCT03808402 - The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS | Biotech Hunter | Biotech Hunter